1 recruiting, 1 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Recruiting 1, Terminated 1 |
Follow Hemorrhagic Cystitis: new trials by email Literature Review of Hemorrhagic Cystitis trials Research Report on Hemorrhagic Cystitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial) Immunonutrition - Bladder Cancer, Interstitial Cystitis | Phase 3 | Recruiting | Centre Hospitalier Universitaire Vaudois | 232 | 2023-04-10 | 2025-12-09 |
| Study to Evaluate Viralym-M (ALVR105) for the Treatment of Virus-Associated Hemorrhagic Cystitis (HC) Posoleucel (ALVR105), Placebo - BK Virus Infection, Hemorrhagic Cystitis | Phase 3 | Terminated | AlloVir | 97 | 2021-03-18 | 2024-05-14 |
Cystitis, Hemorrhagic (2) · Cystitis, Interstitial (1) · Endometriosis (1) · Malnutrition (1) · Urinary Bladder Diseases (1) · Urinary Bladder Neoplasms (1) · Urinary Bladder, Neurogenic (1)
Cystitis (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Male Urogenital Diseases (2) · Urogenital Diseases (2) · Urologic Diseases (2) · Genital Diseases (1) · Genital Diseases, Female (1) · Neoplasms (1) · Neoplasms by Site (1) · Nervous System Diseases (1) · Neurologic Manifestations (1) · Nutrition Disorders (1) · Nutritional and Metabolic Diseases (1) · Pathological Conditions, Signs and Symptoms (1)
AlloVir (1) · Centre Hospitalier Universitaire Vaudois (1)
France (1) · Italy (1) · South Korea (1) · Spain (1) · Sweden (1) · Switzerland (1) · United Kingdom (1) · United States (1)